- Home
- BJ vs MDGL Comparison
BJ vs MDGL Comparison
Compare BJ & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BJ | MDGL |
|---|---|---|
| Founded | 1984 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 11.5B |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BJ | MDGL |
|---|---|---|
| Price | $83.77 | $528.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 12 |
| Target Price | $108.36 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 1.9M | 257.6K |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.50 | ★ 41.32 |
| EPS | ★ 4.38 | N/A |
| Revenue | ★ $21,457,274,000.00 | $180,133,000.00 |
| Revenue This Year | $8.86 | $58.39 |
| Revenue Next Year | $6.50 | $48.55 |
| P/E Ratio | $19.33 | ★ N/A |
| Revenue Growth | ★ 4.66 | N/A |
| 52 Week Low | $83.90 | $265.39 |
| 52 Week High | $115.43 | $615.00 |
Technical Indicators
Market Signals| Indicator | BJ | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 29.99 | 54.31 |
| Support Level | N/A | $498.34 |
| Resistance Level | $95.42 | $548.47 |
| Average True Range (ATR) | 2.64 | 21.52 |
| MACD | -1.11 | -0.39 |
| Stochastic Oscillator | 0.00 | 63.54 |
Price Performance
Historical ComparisonAbout BJ BJ's Wholesale Club Holdings Inc.
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 250 clubs and a growing domestic presence across 21 states. In fiscal 2024, the company generated over $20 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (71% of sales), general merchandise (11%), and gasoline (18%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.